Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIV

Journal of the International AIDS Society 2026 Open access

Read full text
Authors: Lario Viljoen, Charlene Purdy, Verah Luke, Samantha du Toit, Marisa Groenewald, Lindee Ganger, Anneke Catharina Hesseling, Anthony J. Garcia‐Prats, Tim R. Cressey, Adrie Bekker
DOI: 10.1002/jia2.70104
Cited by: 1
References: 11

Abstract

INTRODUCTION: Dolutegravir (DTG) is a key antiretroviral (ARV) drug for children living with HIV, but no specific formulation is available for neonates (

Fields of Study & Subjects

HIV/AIDS drug development and treatment HIV/AIDS Research and Interventions Pharmaceutical studies and practices

Publication details

Journal / source
Journal of the International AIDS Society
Publisher
Wiley
Volume
29
Issue
S1
Pages
e70104–e70104
Publication date
1 June 2026
Language
EN